APA (7th ed.) Citation

J, R., NL, M., C, v. L., SW, T., TH, T., & JG, R. (2021). A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers. Frontiers in pharmacology, 12, 760671. https://doi.org/10.3389/fphar.2021.760671

Chicago Style (17th ed.) Citation

J, Reckweg, Mason NL, van Leeuwen C, Toennes SW, Terwey TH, and Ramaekers JG. "A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers." Frontiers in Pharmacology 12 (2021): 760671. https://doi.org/10.3389/fphar.2021.760671.

MLA (9th ed.) Citation

J, Reckweg, et al. "A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers." Frontiers in Pharmacology, vol. 12, 2021, p. 760671, https://doi.org/10.3389/fphar.2021.760671.